The Bull-Bear Debate In Therapeutics Rages From Research Notes To Twitter
April 20, 2017 at 09:24 AM EDT
TherapeuticsMD Inc (NYSE: TXMD) has waned as much as 40 percent since April 7, when the company received an FDA letter noting ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.